AIG
KRYS icon

American International Group’s Krystal Biotech KRYS Stock Holding History

American International Group’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,652
Closed -$1.9M – 1441
2024
Q1 		$1.9M Sell
10,652
-92
-0.9% -$12.8K 0.01% 1025
2023
Q4 		$1.33M Sell
10,744
-43
-0.4% -$4.77K 0.01% 1157
2023
Q3 		$1.25M Buy
10,787
+383
+4% +$46.7K 0.01% 1128
2023
Q2 		$1.22M Buy
10,404
+108
+1% +$11K 0.01% 1146
2023
Q1 		$824K Buy
10,296
+204
+2% +$16K 0.01% 1317
2022
Q4 		$799K Sell
10,092
-37
-0.4% -$2.75K 0.01% 1328
2022
Q3 		$706K Buy
10,129
+325
+3% +$23.5K 0.01% 1374
2022
Q2 		$644K Sell
9,804
-184
-2% -$11.4K ﹤0.01% 1451
2022
Q1 		$665K Buy
9,988
+457
+5% +$28.5K ﹤0.01% 1569
2021
Q4 		$667K Sell
9,531
-284
-3% -$16.5K ﹤0.01% 1637
2021
Q3 		$512K Sell
9,815
-234
-2% -$13.9K ﹤0.01% 1842
2021
Q2 		$683 Buy
10,049
+1,265
+14% +$88.3K ﹤0.01% 1743
2021
Q1 		$677 Buy
8,784
+925
+12% +$67.2K ﹤0.01% 1670
2020
Q4 		$472 Sell
7,859
-226
-3% -$11.3K ﹤0.01% 1785
2020
Q3 		$348K Buy
8,085
+775
+11% +$33.7K ﹤0.01% 1788
2020
Q2 		$303K Buy
7,310
+1,097
+18% +$52.8K ﹤0.01% 1871
2020
Q1 		$269K Sell
6,213
-360
-5% -$18.8K ﹤0.01% 1742
2019
Q4 		$364K Sell
6,573
-55
-0.8% -$2.7K ﹤0.01% 1873
2019
Q3 		$230K Buy
6,628
+1,056
+19% +$47.2K ﹤0.01% 2083
2019
Q2 		$224K Buy
+5,572
New +$182K ﹤0.01% 2152

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American International Group's KRYS Position: Q2 2024 in Review

American International Group sold out of Krystal Biotech (KRYS) in Q2 2024, closing a stake of 10,652 shares — an estimated $1.9M sold.

American International Group first reported a position in KRYS in Q2 2019 and held it in 20 quarters. The position peaked at $1.9M in Q1 2024. 245 funds tracked by Wall St. Rank hold KRYS as of Q2 2024.

  • American International Group reported no remaining Krystal Biotech position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 10,652 Krystal Biotech shares in Q2 2024, an estimated $1.9M.
  • American International Group first reported a position in Krystal Biotech in Q2 2019 and held it in 20 quarters.
  • American International Group's Krystal Biotech position peaked at $1.9M in Q1 2024.
  • 245 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.